Exploration of mitochondrial dysfunction signaling in inflammatory myopathies, suggesting new therapeutic approaches.
Mitochondrial dysfunction represents a central pathogenic mechanism in IIMs, tightly interwoven with immune-mediated muscle damage. Targeting both inflammatory and mitochondrial pathways may offer more effective and personalised therapeutic strategies for patients with inflammatory myopathies.
No takes yet. Share an insight, caveat, or question.
TORRI et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: